Decision-Making Readiness in Chemotherapy-Treated Lung Cancer Patients

A cross-sectional study from China, published in the open-access journal Nursing Open, finds many hospitalized lung cancer patients receiving chemotherapy feel only moderately ready to participate in treatment decisions. The research team in Beijing surveyed 452 adults with pathologically confirmed lung cancer who were actively on chemotherapy between August and October 2024. Because lung cancer treatment involves repeated choices—from neoadjuvant to adjuvant settings—patients face recurring decisions around risks, side effects, function, and costs. To measure preparedness, investigators used the Chinese version of the Preparation for Decision Making Scale, scoring readiness from 20 to 100; the sample showed strong internal consistency with a Cronbach’s alpha of 0.903.